K Pulaski

Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer

Clinical effectiveness and cost-effectiveness of pegvisomant for the treatment of acromegaly: a systematic review and economic evaluation

A consensus on the diagnosis and treatment of acromegaly complications

Acromegaly

CD44: From adhesion molecules to signalling regulators

Incidence of Vestibular Schwannoma and Neurofibromatosis 2 in the North West of England over a 10-year Period: Higher Incidence than Previously Thought

A survey of MRI-based medical image analysis for brain tumor studies

Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease-Causing Point Mutations

Role of C-Reactive Protein at Sites of Inflammation and Infection

Cushing's syndrome

ERM proteins and merlin: integrators at the cell cortex

Molecular defects in the pathogenesis of pituitary tumours

SWI/SNF nucleosome remodellers and cancer

Birth incidence and prevalence of tumor‐prone syndromes: Estimates from a UK family genetic register service

Medical consequences of acromegaly: What are the effects of biochemical control?

Hereditary Tumor Syndromes and Gliomas

Role of the retinoblastoma protein in the pathogenesis of human cancer.

Three novel types of splicing aberrations in the tuberous sclerosis TSC2 gene caused by mutations apart from splice consensus sequences11Accession numbers and URLs for data in this article are as follows: Online Mendelian Inheritance in Man: http://www.ncbi.nlm.nih.gov/omim. For TSC1 (MIM 191100) and TSC2 (MIM 191092). The Human Gene Mutation Data Base, Cardiff (HGMD): http://www.uwcm.acuk/uwcm/mg. For TSC1 120735 and for TSC2 120466. TSC Variation Database: http://www.expmed.bwh.harvard.edu/projects/tsc_database. GenBank: http://www.ncbi.nlm.nih.gov/Genbank. For TSC2 cDNA X75621 and TSC2 complete genomic sequence AC005600.

The retinoblastoma gene in human pituitary tumors.

High output heart failure in patients with newly diagnosed acromegaly

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein

Human Splicing Finder: an online bioinformatics tool to predict splicing signals

Acromegaly: An Endocrine Society Clinical Practice Guideline

Predictors of the Risk of Mortality in Neurofibromatosis 2

PPAR-γ receptor ligands: novel therapy for pituitary adenomas

A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor

Neurofibromatosis 2: loss of merlin's protective spell

Human Growth Hormone-regulated HOXA1 Is a Human Mammary Epithelial Oncogene

Alterations in body composition in acromegaly

Merlin: the neurofibromatosis 2 tumor suppressor

Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women

Elevated transaminases during medical treatment of acromegaly: a review of the German pegvisomant surveillance experience and a report of a patient with histologically proven chronic mild active hepatitis

Genetic Aberrations in Human Brain Tumors

Cushing's syndrome

Stimulated-emission-depletion microscopy with a multicolor stimulated-Raman-scattering light source

Clonal Analysis of a Case of Multiple Meningiomas Using Multiple Molecular Genetic Approaches: Pathology Case Report

INI1 mutations in meningiomas at a potential hotspot in exon 9

Molecular characterization of chromosome 22 deletions in schwannomas

The structure of the FERM domain of merlin, the neurofibromatosis type 2 gene product

Allelic Loss of 14q and 22q, NF2 Mutation, and Genetic Instability Occur Independently of c‐kit Mutation in Gastrointestinal Stromal Tumor

Guidelines for the diagnosis and management of individuals with neurofibromatosis 1

Brain Tumors

The involvement of calpain-independent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas

Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*

Development of a histological pseudocapsule and its use as a surgical capsule in the excision of pituitary tumors

Optimizing Control of Acromegaly: Integrating a Growth Hormone Receptor Antagonist into the Treatment Algorithm

Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site.

Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management

Biology of Gastrointestinal Stromal Tumors

Messenger ribonucleic acid expression of platelet-derived growth factor subunits and receptors in pituitary adenomas.

The Diagnostic Evaluation and Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2

Genetic Aberrations in Human Brain Tumors

Janus Kinases and Focal Adhesion Kinases Play in the 4.1 Band: A Superfamily of Band 4.1 Domains Important for Cell Structure and Signal Transduction

An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin).

PPAR-γ receptor ligands: novel therapy for pituitary adenomas

Diagnostic criteria for schwannomatosis

Analysis of meningiomas by methylation- and transcription-based clonality assays.

The Molecular Pathogenesis of Corticotroph Tumors

Growth hormone secretion in recently operated acromegalic patients.

Evaluation of clinical diagnostic criteria for neurofibromatosis 2

Female Gonadal Function before and after Treatment of Acromegaly

Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease.

Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus.

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly-2011 Update

Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor

Telomerase Activity in Human Gliomas

Effects of a growth hormone receptor antagonist on bone markers in acromegaly

Clonal origin of pituitary adenomas

Exon scanning for mutation of the NF2 gene in schwannomas

Hypogonadism in patients with acromegaly: data from the multi‐centre acromegaly registry pilot study

Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities.

Clonal analysis of human meningiomas and schwannomas.

Cardiovascular Risk Factors in Acromegaly before and after Normalization of Serum IGF-I Levels with the GH Antagonist Pegvisomant

Mutational analysis of patients with neurofibromatosis 2.